Cocrystal PharmaCOCP

13F holders, Q3 2024 (September 30)
20holders +6
6new positions
0sold out
1famous investor
$1.76avg. 13F price*

At the end of Q3 2024, 20 institutions reported holding Cocrystal Pharma Inc. (COCP) in their 13F filings, up 6 from Q2 2024. 6 opened new positions and 0 sold out. The largest holders were Vanguard Group Inc. ($485K), Renaissance Technologies ($229K) and BlackRock, Inc. ($130K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Cocrystal Pharma Inc.
CUSIP
19188J409
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 16Q1 2024Q2 2024: 14Q2 2024Q3 2024: 20Q3 2024Q4 2024: 24Q4 2024Q1 2025: 24Q1 2025Q2 2025: 22Q2 2025Q3 2025: 22Q3 2025Q4 2025: 28Q4 2025Q1 2026: 26Q1 2026Q2 2026: 27Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions6$55K
Exits0$0

All 13F filers, Q2 2024 → Q3 2024: 45,875 shares bought and 955 shares sold, net +44,920 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

Vanguard Group Inc. 0.00% No change 275,656 $485K
Renaissance Technologies 0.00% Add +0.1% 130,028 $229K
BlackRock, Inc. 0.00% — 73,746 $130K
Geode Capital Management, LLC 0.00% Add +2.2% 66,260 $117K
Morgan Stanley 0.00% No change 59,300 $104K
Susquehanna International Group, LLP 0.00% Add +50.9% 37,800 $67K
State Street Corp. 0.00% No change 20,543 $36K
Parallel Advisors, LLC 0.00% New 15,228 $27K
Dimensional Fund Advisors LP 0.00% New 14,092 $25K
Northern Trust Corp. 0.00% No change 12,171 $21K
Bank of America Corp. 0.00% Add +0.2% 9,050 $16K
Tower Research Capital LLC (TRC) 0.00% Reduce -25.5% 2,743 $5K
UBS Group AG 0.00% New 910 $2K
Northwestern Mutual Wealth Management Co. 0.00% New 817 $1K
Clean Yield Group 0.00% New 418 $736
JPMorgan Chase & Co. 0.00% Reduce -4.0% 411 $723
Nvwm, LLC 0.00% No change 84 $148
Osaic Holdings, Inc. 0.00% New 17 $29
Activest Wealth Management 0.00% No change 1 $2
Royal Bank of Canada 0.00% No change 51 $0

"% of holder's portfolio" is COCP's weight in each manager's 13F, not the share of Cocrystal Pharma Inc. the manager owns.